Published in Arch Intern Med on August 11, 2008
Vitamin D deficiency and risk of cardiovascular disease. Circulation (2008) 13.39
The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab (2010) 13.29
Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med (2013) 9.87
Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ (2014) 7.21
Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ (2014) 5.88
Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med (2010) 5.36
Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. JAMA (2012) 3.10
Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events. JAMA (2013) 2.98
25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol (2009) 2.87
The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev (2012) 2.71
Incidence of hypercalciuria and hypercalcemia during vitamin D and calcium supplementation in older women. Menopause (2014) 2.61
Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol (2011) 2.56
Vitamin D insufficiency in pregnant and nonpregnant women of childbearing age in the United States. Am J Obstet Gynecol (2010) 2.54
Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int (2009) 2.52
Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes (2012) 2.43
Vitamin D for health: a global perspective. Mayo Clin Proc (2013) 2.41
Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey. Osteoporos Int (2010) 2.35
Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 2.25
Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol (2009) 2.13
Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma. J Clin Oncol (2010) 2.06
Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial. J Gerontol A Biol Sci Med Sci (2009) 2.01
Vitamin D and prevention of cardiovascular disease and diabetes: why the evidence falls short. JAMA (2011) 1.99
Cardiovascular effects of calcium supplementation. Osteoporos Int (2011) 1.96
High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care (2012) 1.93
Measurement by a Novel LC-MS/MS Methodology Reveals Similar Serum Concentrations of Vitamin D-Binding Protein in Blacks and Whites. Clin Chem (2015) 1.76
Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol (2011) 1.72
Vitamin D, race, and cardiovascular mortality: findings from a national US sample. Ann Fam Med (2010) 1.72
Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients. Eur Heart J (2010) 1.72
Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. J Endocrinol (2008) 1.72
25-hydroxyvitamin D levels, race, and the progression of kidney disease. J Am Soc Nephrol (2009) 1.71
Benefit-risk assessment of vitamin D supplementation. Osteoporos Int (2009) 1.70
Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr (2013) 1.63
Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci (2009) 1.62
Worsening severity of vitamin D deficiency is associated with increased length of stay, surgical intensive care unit cost, and mortality rate in surgical intensive care unit patients. Am J Surg (2012) 1.62
Changing Incidence of Serum 25-Hydroxyvitamin D Values Above 50 ng/mL: A 10-Year Population-Based Study. Mayo Clin Proc (2015) 1.58
Vitamin D deficiency is associated with subclinical carotid atherosclerosis: the Northern Manhattan study. Stroke (2011) 1.57
Relationship between vitamin D status and left ventricular geometry in a healthy population: results from the Baltimore Longitudinal Study of Aging. J Intern Med (2012) 1.54
Vitamin D deficiency is associated with mortality in the medical intensive care unit. Crit Care (2011) 1.52
Serum vitamin D concentration status and its correlation with early biomarkers of remodeling following acute myocardial infarction. Clin Res Cardiol (2011) 1.52
Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism. Nat Rev Nephrol (2009) 1.51
Determining vitamin D status: a comparison between commercially available assays. PLoS One (2010) 1.49
Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older adults: a cohort study. Ann Intern Med (2012) 1.49
Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis. Am J Nephrol (2015) 1.46
25-Hydroxyvitamin D deficiency is associated with fatal stroke among whites but not blacks: The NHANES-III linked mortality files. Nutrition (2012) 1.44
High prevalence of vitamin D deficiency among healthy Saudi Arabian men: relationship to bone mineral density, parathyroid hormone, bone turnover markers, and lifestyle factors. Osteoporos Int (2011) 1.44
Vitamin D deficiency, interleukin 17, and vascular function in rheumatoid arthritis. J Rheumatol (2013) 1.44
Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin Endocrinol Metab (2012) 1.42
Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr (2009) 1.42
Acute fluid shifts influence the assessment of serum vitamin D status in critically ill patients. Crit Care (2010) 1.40
First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia. Hypertension (2010) 1.39
Is there a reverse J-shaped association between 25-hydroxyvitamin D and all-cause mortality? Results from the U.S. nationally representative NHANES. J Clin Endocrinol Metab (2013) 1.39
25-Hydroxyvitamin D, parathyroid hormone, and mortality in black and white older adults: the health ABC study. J Clin Endocrinol Metab (2012) 1.33
Vitamin D, parathyroid hormone, and sudden cardiac death: results from the Cardiovascular Health Study. Hypertension (2011) 1.29
Vitamin D levels, microvascular complications, and mortality in type 1 diabetes. Diabetes Care (2011) 1.28
Focus on vitamin D, inflammation and type 2 diabetes. Nutrients (2012) 1.27
Vitamin D affects survival independently of vascular calcification in chronic kidney disease. Clin J Am Soc Nephrol (2009) 1.26
Seasonal genetic influence on serum 25-hydroxyvitamin D levels: a twin study. PLoS One (2009) 1.25
Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiol Rev (2016) 1.25
Vitamin D: The "sunshine" vitamin. J Pharmacol Pharmacother (2012) 1.24
Vitamin D deficiency and frailty in older Americans. J Intern Med (2010) 1.23
Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromsø Study. PLoS One (2012) 1.23
Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis. Atherosclerosis (2009) 1.21
Vitamin D levels and mortality in type 2 diabetes. Diabetes Care (2010) 1.21
25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Rheum (2009) 1.20
Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control (2011) 1.18
Pilot study of vitamin D supplementation in adults with cystic fibrosis pulmonary exacerbation: A randomized, controlled trial. Dermatoendocrinol (2012) 1.17
Vitamin D deficiency, self-reported physical activity and health-related quality of life: the Comprehensive Dialysis Study. Nephrol Dial Transplant (2011) 1.15
Association of serum 25-hydroxyvitamin D with the risk of death in a general older population in Finland. Eur J Nutr (2010) 1.14
Effect of follow-up time on the relation between prediagnostic serum 25-hydroxyvitamin D and all-cause mortality rate. Dermatoendocrinol (2012) 1.13
Potential for vitamin D receptor agonists in the treatment of cardiovascular disease. Br J Pharmacol (2009) 1.13
Evidence for a U-shaped relationship between prehospital vitamin D status and mortality: a cohort study. J Clin Endocrinol Metab (2014) 1.12
Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006). Cancer Res (2010) 1.12
Evidence-based D-bate on health benefits of vitamin D revisited. Dermatoendocrinol (2012) 1.12
Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men. J Clin Endocrinol Metab (2010) 1.11
Vitamin D in HIV-Infected Patients. Curr HIV/AIDS Rep (2011) 1.11
Meta-analysis of all-cause mortality according to serum 25-hydroxyvitamin D. Am J Public Health (2014) 1.10
Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats. Endocrinology (2012) 1.10
Vitamin D therapy in chronic kidney disease and end stage renal disease. Clin J Am Soc Nephrol (2011) 1.09
Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats. Am J Pathol (2010) 1.09
Vitamin D status is associated with sociodemographic factors, lifestyle and metabolic health. Eur J Nutr (2012) 1.08
Epidemic vitamin D deficiency among patients in an elderly care rehabilitation facility. Dtsch Arztebl Int (2012) 1.08
Vitamin D levels predict all-cause and cardiovascular disease mortality in subjects with the metabolic syndrome: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. Diabetes Care (2012) 1.05
Vitamin D status and parathyroid hormone in a urban population in Vietnam. Osteoporos Int (2010) 1.05
Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteoporos Int (2009) 1.04
Meta-analysis of long-term vitamin D supplementation on overall mortality. PLoS One (2013) 1.03
The biology and pathology of vitamin D control in bone. J Cell Biochem (2010) 1.03
Association of glucocorticoid use and low 25-hydroxyvitamin D levels: results from the National Health and Nutrition Examination Survey (NHANES): 2001-2006. J Clin Endocrinol Metab (2011) 1.03
Vitamin D suppression of endoplasmic reticulum stress promotes an antiatherogenic monocyte/macrophage phenotype in type 2 diabetic patients. J Biol Chem (2012) 1.02
Vitamin d and serum cytokines in a randomized clinical trial. Int J Endocrinol (2010) 1.01
Association of vitamin D insufficiency with carotid intima-media thickness in HIV-infected persons. Clin Infect Dis (2011) 1.00
Vitamin D-insufficiency: An estimate of the situation in Germany. Dermatoendocrinol (2012) 0.99
Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen. AIDS Res Ther (2010) 0.99
Vitamin D: roles in renal and cardiovascular protection. Curr Opin Nephrol Hypertens (2012) 0.99
A prospective study of serum 25-hydroxyvitamin D levels, blood pressure, and incident hypertension in postmenopausal women. Am J Epidemiol (2011) 0.99
Calcium and vitamin D intake and mortality: results from the Canadian Multicentre Osteoporosis Study (CaMos). J Clin Endocrinol Metab (2013) 0.99
Vitamin D status and cause-specific mortality: a general population study. PLoS One (2012) 0.98
Vitamin D status and outcomes after renal transplantation. J Am Soc Nephrol (2013) 0.97
Low serum 25-hydroxyvitamin D concentrations are associated with greater all-cause mortality in older community-dwelling women. Nutr Res (2009) 0.97
Low serum vitamin D is associated with increased mortality in elderly men: MrOS Sweden. Osteoporos Int (2011) 0.97
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med (2000) 29.25
National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med (2003) 23.33
Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med (2004) 17.79
Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. Vital Health Stat 1 (1994) 12.36
Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA (2007) 11.87
Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr (2000) 11.69
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol (2004) 11.23
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr (2006) 10.95
1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest (2002) 9.50
Hypovitaminosis D in medical inpatients. N Engl J Med (1998) 9.13
Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med (2007) 7.87
Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst (2006) 7.19
Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis (2002) 7.03
Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension (2007) 6.99
Calcium/vitamin D supplementation and cardiovascular events. Circulation (2007) 6.63
Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int (2006) 6.61
Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int (2007) 6.35
Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med (2007) 6.29
Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone (2002) 6.02
Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med (2007) 5.26
Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care (2006) 4.62
Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care (2005) 4.47
Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol (2005) 4.44
Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab (2004) 3.75
25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int (2006) 3.64
Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int (2006) 3.63
Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab (2001) 3.51
Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int (2006) 3.36
Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab (2003) 3.22
Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant (2004) 3.06
The prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethn Dis (2005) 3.04
Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol (2003) 2.97
Ultraviolet B and blood pressure. Lancet (1998) 2.83
Sample design: Third National Health and Nutrition Examination Survey. Vital Health Stat 2 (1992) 2.77
The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol Med (2002) 2.45
Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr (2005) 2.38
Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care (2006) 2.32
Implementation of the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10). Epidemiol Bull (1997) 2.11
Lifestyle behaviors associated with lower risk of having the metabolic syndrome. Metabolism (2004) 1.87
Vitamin D intake and risk of incident hypertension: results from three large prospective cohort studies. Hypertension (2005) 1.68
Cancer survival is dependent on season of diagnosis and sunlight exposure. Int J Cancer (2006) 1.64
Antiproliferative role of vitamin D and its analogs--a brief overview. Mol Cell Biochem (2003) 1.42
Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease? Kidney Int (2005) 1.38
Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. JAMA (2009) 6.80
A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet (2006) 6.39
Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation (2009) 5.26
Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. Arch Intern Med (2007) 4.58
A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science (2008) 4.50
Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation (2005) 4.27
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation (2007) 4.16
Traditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging: the Multiethnic Study of Atherosclerosis. J Am Coll Cardiol (2006) 2.94
Racial/ethnic differences in hypertension and hypertension treatment and control in the multi-ethnic study of atherosclerosis (MESA). Am J Hypertens (2004) 2.88
25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol (2009) 2.87
Diet soda intake and risk of incident metabolic syndrome and type 2 diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care (2009) 2.70
C-reactive protein is a marker for human immunodeficiency virus disease progression. Arch Intern Med (2006) 2.67
The genetic response to short-term interventions affecting cardiovascular function: rationale and design of the Heredity and Phenotype Intervention (HAPI) Heart Study. Am Heart J (2008) 2.61
Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations. Circulation (2009) 2.55
Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics (2009) 2.46
Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol (2008) 2.32
Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study. AIDS (2008) 2.19
Urine albumin excretion and subclinical cardiovascular disease. The Multi-Ethnic Study of Atherosclerosis. Hypertension (2005) 2.18
Corin I555(P568) allele is associated with enhanced cardiac hypertrophic response to increased systemic afterload. Hypertension (2007) 2.17
Long-term exposure to ambient particulate matter and prevalence of subclinical atherosclerosis in the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol (2008) 2.09
Serum 25-hydroxyvitamin d levels are not associated with subclinical vascular disease or C-reactive protein in the old order amish. Calcif Tissue Int (2009) 1.96
Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction. Circulation (2011) 1.96
Randomized clinical trial of aspirin and simvastatin for pulmonary arterial hypertension: ASA-STAT. Circulation (2011) 1.91
Making the case for selective use of statins in the primary prevention setting. Arch Intern Med (2011) 1.90
Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension. Circulation (2005) 1.84
Comparison of the Framingham Heart Study hypertension model with blood pressure alone in the prediction of risk of hypertension: the Multi-Ethnic Study of Atherosclerosis. Hypertension (2010) 1.75
25-hydroxyvitamin D levels, race, and the progression of kidney disease. J Am Soc Nephrol (2009) 1.71
Increased prevalence of carotid artery atherosclerosis in rheumatoid arthritis is artery-specific. J Rheumatol (2010) 1.69
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. J Am Coll Cardiol (2007) 1.69
Association of the vitamin D metabolism gene CYP24A1 with coronary artery calcification. Arterioscler Thromb Vasc Biol (2010) 1.69
Estimating glomerular filtration rate in the general population: the second Health Survey of Nord-Trondelag (HUNT II). Nephrol Dial Transplant (2006) 1.67
Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging. Arthritis Rheum (2010) 1.63
Genetic association for renal traits among participants of African ancestry reveals new loci for renal function. PLoS Genet (2011) 1.60
Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease. Am J Clin Nutr (2008) 1.56
Blood viscosity and hematocrit as risk factors for type 2 diabetes mellitus: the atherosclerosis risk in communities (ARIC) study. Am J Epidemiol (2008) 1.54
Progression of coronary calcium and incident coronary heart disease events: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol (2013) 1.50
Prediction of incident heart failure in general practice: the Atherosclerosis Risk in Communities (ARIC) Study. Circ Heart Fail (2012) 1.50
Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int (2004) 1.48
Risk factor differences for aortic versus coronary calcified atherosclerosis: the multiethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol (2010) 1.47
Evidence for increased cardiovascular disease risk in patients with chronic kidney disease. Curr Opin Nephrol Hypertens (2004) 1.45
Cardiac tamponade in an orthotopic liver recipient with pulmonary hypertension. Crit Care Med (2002) 1.44
Ethnic differences in the relationship of carotid atherosclerosis to coronary calcification: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis (2007) 1.43
Identification of a sudden cardiac death susceptibility locus at 2q24.2 through genome-wide association in European ancestry individuals. PLoS Genet (2011) 1.38
Coronary arterial calcification in rheumatoid arthritis: comparison with the Multi-Ethnic Study of Atherosclerosis. Arthritis Res Ther (2009) 1.33
25-Hydroxyvitamin D and parathyroid hormone are not associated with carotid intima-media thickness or plaque in the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol (2013) 1.33
Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J (2010) 1.30
Chronic kidney disease prevalence estimates among racial/ethnic groups: the Multi-Ethnic Study of Atherosclerosis. Clin J Am Soc Nephrol (2008) 1.29
Role of troponin in patients with chronic kidney disease and suspected acute coronary syndrome: a systematic review. Ann Intern Med (2014) 1.26
Neighborhood health-promoting resources and obesity risk (the multi-ethnic study of atherosclerosis). Obesity (Silver Spring) (2013) 1.24
Exploring the genetics of longevity in the Old Order Amish. Mech Ageing Dev (2005) 1.24
Prognostic value of cardiac troponin in patients with chronic kidney disease without suspected acute coronary syndrome: a systematic review and meta-analysis. Ann Intern Med (2014) 1.23
Detection of high-risk young adults and women by coronary calcium and National Cholesterol Education Program Panel III guidelines. J Am Coll Cardiol (2005) 1.22
Left ventricular hypertrophy in mild and moderate reduction in kidney function determined using cardiac magnetic resonance imaging and cystatin C: the multi-ethnic study of atherosclerosis (MESA). Am J Kidney Dis (2008) 1.22
Sex steroid hormone concentrations and risk of death in US men. Am J Epidemiol (2010) 1.22
Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis. Atherosclerosis (2009) 1.21
Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics. Arthritis Rheum (2010) 1.21
Effectiveness of MR imaging in selection of patients for arthroscopy of the knee. Radiology (2002) 1.19
COL4A1 is associated with arterial stiffness by genome-wide association scan. Circ Cardiovasc Genet (2009) 1.16
Cholesteryl ester transfer protein genetic polymorphisms, HDL cholesterol, and subclinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis (2008) 1.16
Antiretroviral therapy is associated with an atherogenic lipoprotein phenotype among HIV-1-infected men in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (2008) 1.14
Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions. J Am Coll Cardiol (2006) 1.12
Suboptimal nutritional intake for hypertension control in 4 ethnic groups. Arch Intern Med (2009) 1.11
Vitamin D in atherosclerosis, vascular disease, and endothelial function. Curr Drug Targets (2011) 1.11
Comparison of the racial/ethnic prevalence of regular aspirin use for the primary prevention of coronary heart disease from the multi-ethnic study of atherosclerosis. Am J Cardiol (2011) 1.11
Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis. Semin Arthritis Rheum (2012) 1.10
Associations between two common polymorphisms in the ABCA1 gene and subclinical atherosclerosis: Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis (2006) 1.10
Genome-wide association study identifies GPC5 as a novel genetic locus protective against sudden cardiac arrest. PLoS One (2010) 1.09
Further improvements in CHD risk prediction for women. JAMA (2007) 1.06
Multiple independent genetic factors at NOS1AP modulate the QT interval in a multi-ethnic population. PLoS One (2009) 1.05
The association of coronary artery calcification and carotid artery intima-media thickness with distinct, traditional coronary artery disease risk factors in asymptomatic adults. Am J Epidemiol (2008) 1.04
Evidence-based use of statins for primary prevention of cardiovascular disease. Am J Med (2012) 1.03
Vitamin D supplementation and cardiovascular disease risk. Circulation (2007) 1.00
Pulmonary hyperinflation and left ventricular mass: the Multi-Ethnic Study of Atherosclerosis COPD Study. Circulation (2013) 0.99
Gene-centric meta-analysis of lipid traits in African, East Asian and Hispanic populations. PLoS One (2012) 0.99
Prediction of coronary artery calcium progression in individuals with low Framingham Risk Score: the Multi-Ethnic Study of Atherosclerosis. JACC Cardiovasc Imaging (2012) 0.98
Association of SCARB1 variants with subclinical atherosclerosis and incident cardiovascular disease: the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol (2012) 0.98
Methylomics of gene expression in human monocytes. Hum Mol Genet (2013) 0.97
Factors associated with low levels of subclinical vascular disease in older adults: multi-ethnic study of atherosclerosis. Prev Cardiol (2009) 0.96
Very large database of lipids: rationale and design. Clin Cardiol (2013) 0.96
Impaired left ventricular filling in COPD and emphysema: is it the heart or the lungs? The Multi-Ethnic Study of Atherosclerosis COPD Study. Chest (2013) 0.95
Integrative predictive model of coronary artery calcification in atherosclerosis. Circulation (2009) 0.94
Vitamin D, calcium, and atherosclerotic risk: evidence from serum levels and supplementation studies. Curr Atheroscler Rep (2013) 0.93
Activated TLR signaling in atherosclerosis among women with lower Framingham risk score: the multi-ethnic study of atherosclerosis. PLoS One (2011) 0.92
Circulating CD34+ Cell Count is Associated with Extent of Subclinical Atherosclerosis in Asymptomatic Amish Men, Independent of 10-Year Framingham Risk. Clin Med Cardiol (2009) 0.92
Endogenous sex steroid hormones and measures of chronic kidney disease (CKD) in a nationally representative sample of men. Clin Endocrinol (Oxf) (2008) 0.92
Invited commentary: The association of low vitamin D with cardiovascular disease--getting at the "heart and soul" of the relationship. Am J Epidemiol (2014) 0.92
Comparison of gadolinium-enhanced cardiovascular magnetic resonance angiography with high-resolution black blood cardiovascular magnetic resonance for assessing carotid artery stenosis. J Cardiovasc Magn Reson (2007) 0.92
Geographic variation in hypertension prevalence among blacks and whites: the multi-ethnic study of atherosclerosis. Am J Hypertens (2009) 0.92
Association between levels of blood pressure and measures of subclinical disease multi-ethnic study of atherosclerosis. Am J Hypertens (2006) 0.91
Association of scavenger receptor class B type I polymorphisms with subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Genet (2009) 0.90
Statistical modeling of Agatston score in multi-ethnic study of atherosclerosis (MESA). PLoS One (2010) 0.89
Genetic influences on blood pressure response to the cold pressor test: results from the Heredity and Phenotype Intervention Heart Study. J Hypertens (2008) 0.89
The JUPITER and AURORA clinical trials for rosuvastatin in special primary prevention populations: perspectives, outcomes, and consequences. Vasc Health Risk Manag (2009) 0.89
Therapy Insight: managing cardiovascular risk in patients with rheumatoid arthritis. Nat Clin Pract Rheumatol (2006) 0.88
The HALTS trial--halting atherosclerosis or halted too early? N Engl J Med (2009) 0.86
Association of left ventricular hypertrophy with incident hypertension: the multi-ethnic study of atherosclerosis. Am J Epidemiol (2011) 0.86
Clinical outcomes and dialysis adequacy in adolescent hemodialysis patients. Am J Kidney Dis (2006) 0.86
Differences in prevalence and severity of coronary artery calcification between two non-Hispanic white populations with diverse lifestyles. Atherosclerosis (2007) 0.86
Impact of fitness versus obesity on routinely measured cardiometabolic risk in young, healthy adults. Am J Cardiol (2013) 0.86